Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently been diagnosed with an early-stage skin melanoma that is no deeper than 1.0 mm into the skin, confirmed by a full surgical removal and laboratory analysis of the tissue.
- People whose melanoma is in a location on the body where surgery to remove a 10 mm border of surrounding skin would have been the standard planned treatment.
- People whose removed tissue showed that the edges around the melanoma were clear of cancer cells by at least 1.5 mm.
- People who are 18 years of age or older at the time of agreeing to participate.
- People who are able to understand and agree to the study procedures and are willing to attend follow-up appointments.
- People who have a life expectancy of at least 5 years from the time of their melanoma diagnosis.
Who may not be able to join:
- People whose melanoma was only partially removed before the full surgical removal (diagnostic excision) was done.
- People whose melanoma was removed with more than 5 mm of surrounding skin during the initial diagnostic removal.
- People whose melanoma is of a specific type called desmoplastic, lentigo maligna, or acral lentiginous melanoma.
- People whose melanoma is located on a finger or toe where amputation would be required.
- People who have had a previous or current melanoma anywhere on or in the body, at any stage.
- People who have signs — found through physical examination, scans, or laboratory results — that the melanoma has spread to other areas of the body.
- People who have had another type of cancer (solid tumour or blood cancer) within the past 5 years, except for common skin cancers such as squamous cell carcinoma or basal cell carcinoma.
- People for whom additional radiation treatment to the melanoma site has been planned after surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: John Paoli, Professor, Dept. of Dermatology and Venereology, Sahlgrenska Academy, University of Gothenburg, Sweden
Phone: 0730404044
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrence rate at 5 years.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.